Document Detail


A case of rofecoxib-associated stevens-johnson syndrome with corneal and conjunctival changes.
MedLine Citation:
PMID:  15448505     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To report a case of rofecoxib (Vioxx)-associated Stevens-Johnson syndrome with corneal and conjunctival changes. DESIGN: Interventional case report. METHODS: Case report of a 62-year-old woman with systemic lupus erythematosus (SLE) taking rofecoxib for arthritis for 3 weeks. RESULTS: Stevens-Johnson syndrome after 3 weeks of rofecoxib therapy. CONCLUSION: This case report suggests that oral rofecoxib may trigger Stevens-Johnson syndrome, potentially causing symblepharons, corneal neovascularization and cicatricial ectropions.
Authors:
D Goldberg; D Panigrahi; M Barazi; M Abelson; S Butrus
Related Documents :
3183655 - Ganser symptoms, dissociation, and dysprosody.
9210565 - Munchausen syndrome presenting as trauma.
12973285 - Idiopathic lenticular mucocutaneous pigmentation (laugier-hunziker syndrome): a report ...
9717685 - Poliomyelitis-like syndrome following asthmatic attack (hopkins' syndrome)--recovery as...
19836485 - Surgical management of nonmultiple endocrine neoplasia endocrinopathies: state-of-the-a...
17873535 - Dyskeratosis congenita associated with hypocellular myelodysplastic syndrome: a case re...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cornea     Volume:  23     ISSN:  0277-3740     ISO Abbreviation:  Cornea     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-27     Completed Date:  2004-12-02     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8216186     Medline TA:  Cornea     Country:  United States    
Other Details:
Languages:  eng     Pagination:  736-7     Citation Subset:  IM    
Affiliation:
Department of Ophthalmology, The Georgetown University-Washington Hospital Center, Washington, DC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arthralgia / drug therapy
Conjunctiva / pathology*
Cornea / pathology*
Cyclooxygenase Inhibitors / adverse effects*
Female
Humans
Lactones / adverse effects*
Middle Aged
Stevens-Johnson Syndrome / chemically induced*,  pathology*
Sulfones
Chemical
Reg. No./Substance:
0/Cyclooxygenase Inhibitors; 0/Lactones; 0/Sulfones; 0/rofecoxib

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevention of recurrent Reis-Bücklers dystrophy following excimer laser phototherapeutic keratectomy...
Next Document:  Primary meningococcal conjunctivitis in an adult.